We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.
- Authors
Blum, William; Klisovic, Rebecca B; Hackanson, Bjoern; Liu, Zhongfa; Liu, Shujun; Devine, Hollie; Vukosavljevic, Tamara; Huynh, Lenguyen; Lozanski, Gerard; Kefauver, Cheryl; Plass, Christoph; Devine, Steven M; Heerema, Nyla A; Murgo, Anthony; Chan, Kenneth K; Grever, Michael R; Byrd, John C; Marcucci, Guido
- Abstract
To determine an optimal biologic dose (OBD) of decitabine as a single agent and then the maximum-tolerated dose (MTD) of valproic acid (VA) combined with decitabine in acute myeloid leukemia (AML).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 25, p3884
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.09.4169